In the past ten years, the United States and Europe owned by 20 to 50 percent increase in pneumonia hospitalization seen. Die also about 10 to 15 percent of patients of pneumonia of the disease. It has been proposed in a review article that with with bloodstream infections or with the presence of bacteria in the bloodstream of the ability of statins to benefit from clotting, act inflammation, and modifications of immune functions.
‘Our study adds to the accumulating evidence that statins be associated with improved prognosis after severe infections,’the authors say. ‘The decrease in mortality associated with statin use associated appears to be in patients with pneumonia in hospital admission require significantly. Randomized trials are needed to causality of the associations was observational studies observational studies. Given the availability of statins, with their relatively low cost and mild side effects effects had positive results of statin therapy trials in patients with pneumonia have significant clinical and public health implications.The metastatic -associated protein CD24 found within a tumor has been were identified as a novel prognostic factor and stem cell marker, however the significance of CD24 at NSCLCs clearly clear through ago current research. In order to clarify the understanding of the present study led a retrospective study of prognostic factor for analytical by evaluation CD24 expression in 267 successive cases on NSCLC. P tissue microarray technique, the team analyzed immunohistochemistry to correlates with clinically.
Few years with an progression-free survival and cancer-specific survival correlate, independent of tumor histology. ‘overexpress overexpressed during cancer progression is of particular interest because they are be used not only to predict the outcome of patients but also serve to as potential targets in cancer therapy, such epidermal growth factor receptor gene be, ‘the principal investigator Dr. Hyun Ju Lee heads the impact of the research results of.. Prior to the revision in the TNM, was the most important traditional prognostic factor for patient survival tumor staging the time of diagnosis, including tumor quantity, pleural invasion, inclusion of regional lymph and metastasis to distant organs.